Gefitinib for recurrent non-small-cell lung cancer: All things are not created equal

被引：2

作者：

Dahlberg, Suzanne E. ^{[1
]}

Gray, Robert J. ^{[1
]}

Johnson, Bruce E. ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 26期

关键词：

D O I：

10.1200/JCO.2008.17.0837

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：4233 / 4235

页数：3

共 12 条

[1] Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE):: A randomized, phase II study [J].

Crino, Lucio ;

Cappuzzo, Federico ;

Zatloukal, Petr ;

Reck, Martin ;

Pesek, Milos ;

Thompson, Joyce C. ;

Ford, Hugo E. R. ;

Hirsch, Fred R. ;

Varella-Garcia, Marileila ;

Ghiorghiu, Serban ;

Duffield, Emma L. ;

Armour, Alison A. ;

Speake, Georgina ;

Cullen, Michael .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (26) :4253-4260

[2] Gefitinib (IRESSA) versus docetaxel in patients with locally advanced or metastatic non-small-cell lung cancer pre-treated with platinum-based chemotherapy: a randomized, open-label Phase III study (INTEREST) [J].

Douillard, Jean-Yves ;

Kim, Edward ;

Hirsh, Vera ;

Mok, Tony ;

Socinski, Mark ;

Gervais, Radj ;

Wu, Yi-Long ;

Li, Longyun ;

Sellers, Mark ;

Lowe, Elizabeth .

JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) :S305-S306

[3] Randomized clinical trial design for assessing noninferiority when superiority is expected [J].

Freidlin, Boris ;

Korn, Edward L. ;

George, Stephen L. ;

Gray, Robert .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (31) :5019-5023

[4]

Gridelli C, 1999, JNCI-J NATL CANCER I, V91, P66

[5] Quality of reporting of noninferiority and equivalence randomized trials [J].

Le Henanff, A ;

Giraudeau, B ;

Baron, G ;

Ravaud, P .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (10) :1147-1151

[6]

MAKUCH R, 1978, CANCER TREAT REP, V62, P1037

[7] Phase III study, V-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer [J].

Maruyama, Riichiroh ;

Nishiwaki, Yutaka ;

Tamura, Tomohide ;

Yamamoto, Nobuyuki ;

Tsuboi, Masahiro ;

Nakagawa, Kazuhiko ;

Shinkai, Tetsu ;

Negoro, Shunichi ;

Imamura, Fumio ;

Eguchi, Kenji ;

Takeda, Koji ;

Inoue, Akira ;

Tomii, Keisuke ;

Harada, Masao ;

Masuda, Noriyuki ;

Jiang, Haiyi ;

Itoh, Yohji ;

Ichinose, Yukito ;

Saijo, Nagahiro ;

Fukuoka, Masahiro .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (26) :4244-4252

[8] Reporting of noninferiority and equivalence randomized trials - An extension of the CONSORT Statement [J].

Piaggio, G ;

Elbourne, DR ;

Altman, DG ;

Pocock, SJ ;

Evans, SJW .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (10) :1152-1160

[9] Design and analysis of non-inferiority mortality trials in oncology [J].

Rothmann, M ;

Li, N ;

Chen, G ;

Chi, GYH ;

Temple, R ;

Tsou, HH .

STATISTICS IN MEDICINE, 2003, 22 (02) :239-264

[10] Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy [J].

Shepherd, FA ;

Dancey, J ;

Ramlau, R ;

Mattson, K ;

Gralla, R ;

O'Rourke, M ;

Levitan, N ;

Gressot, L ;

Vincent, M ;

Burkes, R ;

Coughlin, S ;

Kim, Y ;

Berille, J .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (10) :2095-2103

← 1 2 →